Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.130
+0.080 (3.90%)
At close: Aug 18, 2025, 4:00 PM
2.100
-0.030 (-1.41%)
After-hours: Aug 18, 2025, 4:28 PM EDT

Ensysce Biosciences Revenue

Ensysce Biosciences had revenue of $1.37M in the quarter ending June 30, 2025, with 654.38% growth. This brings the company's revenue in the last twelve months to $7.41M, up 415.58% year-over-year. In the year 2024, Ensysce Biosciences had annual revenue of $5.21M with 133.58% growth.

Revenue (ttm)
$7.41M
Revenue Growth
+415.58%
P/S Ratio
0.37
Revenue / Employee
$926,715
Employees
8
Market Cap
6.32M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.21M2.98M133.58%
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 20203.93M2.17M122.86%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.